BCNU toxicity presenting with a large pericardial and pleural effusion

Annals of Transplantation

Volumn 13, Issue 1, 2008, Pages 44-47

  Krishnan, Ganapathy S ^a   Chaudhary, Vijay ^a   Al Janadi, Anas ^a   Ramanarayanan, Jeyanthi ^b   D'Silva, Karl J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Adult t cell lymphoma; BCNU; Pericardial effusion; Pleural effusion

Indexed keywords

CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; PREDNISONE; VINCRISTINE; ALKYLATING AGENT; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; FLUTICASONE;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BRONCHOSCOPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DOPPLER ECHOCARDIOGRAPHY; DRUG MEGADOSE; DYSPNEA; FEMALE; HEART TAMPONADE; HUMAN; LUNG INFILTRATE; PERICARDIAL EFFUSION; PLEURA EFFUSION; RADIOTHERAPY; T CELL LYMPHOMA; THORAX PAIN; CHEMICALLY INDUCED DISORDER; ECHOCARDIOGRAPHY; ECHOGRAPHY; RADIOGRAPHY; STEM CELL TRANSPLANTATION;

ADULT; ANDROSTADIENES; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LYMPHOMA, T-CELL; PERICARDIAL EFFUSION; PLEURAL EFFUSION; STEM CELL TRANSPLANTATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48549084692     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cao TM, Negrin RS, Stockerl-Goldstein KE et al: Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant, 2000; 6: 387-394
2. Malik SW, Myers JL, DeRemee RA, Specks U: Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med, 1996; 154: 1851-1856
3. Anscher MS, Peters WP, Reisenbichler H et al: Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med, 1993; 328: 1592-1598
4. Shen YC, Chiu CF, Chow KC et al: Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase- 2. Bone Marrow Transplant, 2004; 34: 609-614
5. Rubio C, Hill ME, Milan S et al: Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease. Br J Cancer, 1997; 75: 1044-1048
6. Escalon MP, Liu NS, Yang Y et al: Prognostic factors and treatment of patients with T-cell non- Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer, 2005; 103: 2091-2098
7. Buser AS, Stern M, Bucher C et al: High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation. Bone Marrow Transplant, 2007; 39: 335-340
8. Wilczynski SW, Erasmus JJ, Petros WP et al: Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med, 1998;157: 565-573
9. Selker RG, Jacobs SA, Moore PB et al: 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis. Neurosurgery, 1980; 7: 560-565
10. Phillips GL, Fay JW, Herzig GP et al: Intensive 1,3- bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer, 1983; 52: 1792-1802
11. Chap L, Shpiner R, Levine M et al: Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. Bone Marrow Transplant, 1997; 20: 1063-1067
12. Lund MB, Kongerud J, Boe J et al: Cardiopulmonary sequelae after treatment for Hodgkin's disease: increased risk in females? Ann Oncol, 1996; 7: 257-264
13. Wong R, Rondon G, Saliba RM et al: Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer. Bone Marrow Transplant, 2003; 31: 1157-1163
14. McGaughey DS, Nikcevich DA, Long GD et al: Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation. Biol Blood Marrow Transplant, 2001; 7: 274-278
15. Suratt BT, Lynch DA, Cool CD et al: Interferongamma for delayed pulmonary toxicity syndrome resistant to steroids. Bone Marrow Transplant, 2003; 31: 939-941
16. Raghu G, Brown KK, Bradford WZ et al: A placebo- controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fi brosis. N Engl J Med, 2004; 350: 125-133
17. Kalaycioglu M, Kavuru M, Tuason L, Bolwell B: Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine (BCNU). Chest, 1995; 107: 482-487